{"id":"NCT04036292","sponsor":"Oyster Point Pharma, Inc.","briefTitle":"Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","officialTitle":"Multicenter, Randomized, Controlled, Double-Masked, Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease (The ONSET-2 Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-07-23","primaryCompletion":"2020-04-10","completion":"2021-02-05","firstPosted":"2019-07-29","resultsPosted":"2021-11-22","lastUpdate":"2021-11-22"},"enrollment":758,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Dry Eye Disease (DED)"],"interventions":[{"type":"DRUG","name":"OC-01 (varenicline) nasal spray","otherNames":[]},{"type":"DRUG","name":"Placebo (vehicle) nasal spray","otherNames":[]}],"arms":[{"label":"OC-01 Low Dose, 0.6 mg/mL","type":"ACTIVE_COMPARATOR"},{"label":"OC-01 High Dose, 1.2 mg/mL","type":"ACTIVE_COMPARATOR"},{"label":"Placebo (vehicle) nasal spray","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this study is to evaluate the safety and effectiveness of OC-01 Nasal Spray as compared to placebo on signs and symptoms of dry eye disease.","primaryOutcome":{"measure":"Percent of Subjects Who Achieve â‰¥10 mm Improvement in Schirmer's Test Score From Baseline at Visit 4 (Day 28)","timeFrame":"28 Days [Visit 1 (baseline) and Visit 4b (28 days)]","effectByArm":[{"arm":"OC-01 Low Dose, 0.6 mg/mL","deltaMin":123,"sd":null},{"arm":"OC-01 High Dose, 1.2 mg/mL","deltaMin":121,"sd":null},{"arm":"Placebo (Vehicle) Nasal Spray","deltaMin":70,"sd":null}],"pValues":[]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":5},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":["37096956","36401081","34767866"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":260},"commonTop":["Sneezing","Cough","Throat irritation","Instillation site irritation","Nasopharyngitis"]}}